Birmingham, West Midlands -- (SBWIRE) -- 12/12/2013 -- Value Penny Stocks issues special report on Geron Corporation (NASDAQ:GERN), Office Depot Inc (NYSE:ODP), Magnum Hunter Resources Corp (NYSE:MHR), Galena Biopharma Inc (NASDAQ:GALE).
Geron Corporation (NASDAQ:GERN) opened its last trade at the price of $5.17. Its closing price was $4.66 after losing -9.51% for the day. The company traded with the total volume of 8.58 million shares, while its average trading volume remained 7.72 million shares. The beta of this stock stands at 1.24. Geron Corporation is a clinical stage biopharmaceutical company developing a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. The company was founded in 1990 and is based in Menlo Park, California.
Has GERN Found The Bottom and Ready To Move Up? Find Out Here
Office Depot Inc (NYSE:ODP) percentage change plunged -1.67% to close at $5.29 with the total traded volume of 8.55 million shares, along with average volume of 12.23 million shares. The 52 week range of the stock remained $3.17 - $6.10, while its day lowest price was $5.24. The share price hit the day highest price of $5.43. Office Depot, Inc., together with its subsidiaries, supplies office products and services. Its North American Retail division sells an assortment of merchandise, such as general office supplies, computer supplies, business machines and related supplies, and office furniture under various labels.
Has ODP Found The Bottom And Ready To Gain Momentum? Find Out Here
Magnum Hunter Resources Corp (NYSE:MHR) traded on volume of 8.47 million shares in the last session against average volume of 5.25 million shares. The company started its trading session with the price of $6.47 and closed at $6.10 by scoring -6.15%. Magnum Hunter Resources Corporation, an independent oil and gas company, engages in the exploration, exploitation, acquisition, development, and production of crude oil, natural gas, and natural gas liquid resources in the United States and Canada.
Why Should Investors Buy MHR After the Recent Fall? Just Go Here and Find Out
Galena Biopharma Inc (NASDAQ:GALE) started its last trading session with the price of $3.79 and closed at $4.18 by scoring 5.32%. The stock traded with total volume of 7.80 million shares, while the average trading volume remained 5.86 million shares. The beta value of this stock stands at 1.10. Day range for the stock was $3.69 - $4.20. Galena Biopharma, Inc., a biopharmaceutical company, focuses on developing oncology treatments to address major unmet medical needs to advance cancer care. It is developing a pipeline of immunotherapy product candidates for the treatment of various cancers based on the E75 peptide.
Why Should Investors Buy GALE After The Recent Gain? Just Go Here and Find Out
About Value Penny Stocks:
Value Penny Stocks was made by Two Active traders, Steve and Wilson, whom have made a platform for traders in order to provide traders the #1 Penny Stock Newsletter which actually gives value to your money and makes your portfolio full of profits. We concentrate on small cap stocks that trade on NYSE, NASD, AMEX, OTCBB, and OTC exchanges. These are usually stocks that will trade under $5 a share and offer the utmost potential profit on your short or long term investment. We also devote ourselves to understanding the overall market situations and use this knowledge in order to gain a better perception during our stock picking decisions.
We at ValuePennyStocks.com are engaged in the business of marketing and advertising companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Please Read Our Full Disclaimer at: http://www.valuepennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)